Detalhe da pesquisa
1.
Palb2 synergizes with Trp53 to suppress mammary tumor formation in a model of inherited breast cancer.
Proc Natl Acad Sci U S A
; 110(21): 8632-7, 2013 May 21.
Artigo
Inglês
| MEDLINE | ID: mdl-23657012
2.
Distinct cardiotoxic effects by venoms of a spitting cobra (Naja pallida) and a rattlesnake (Crotalus atrox) revealed using an ex vivo Langendorff heart model.
Toxicon
; 240: 107637, 2024 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-38331109
3.
Challenging Future Generations: A Qualitative Study of Students' Attitudes toward the Transition to Animal-Free Innovations in Education and Research.
Animals (Basel)
; 13(3)2023 Jan 24.
Artigo
Inglês
| MEDLINE | ID: mdl-36766283
4.
Loss of p53 partially rescues embryonic development of Palb2 knockout mice but does not foster haploinsufficiency of Palb2 in tumour suppression.
J Pathol
; 224(1): 10-21, 2011 May.
Artigo
Inglês
| MEDLINE | ID: mdl-21404276
5.
BRCA1-deficient mammary tumor cells are dependent on EZH2 expression and sensitive to Polycomb Repressive Complex 2-inhibitor 3-deazaneplanocin A.
Breast Cancer Res
; 11(4): R63, 2009.
Artigo
Inglês
| MEDLINE | ID: mdl-19709408
6.
Selective inhibition of BRCA2-deficient mammary tumor cell growth by AZD2281 and cisplatin.
Clin Cancer Res
; 14(12): 3916-25, 2008 Jun 15.
Artigo
Inglês
| MEDLINE | ID: mdl-18559613
7.
Selected Alkylating Agents Can Overcome Drug Tolerance of G0-like Tumor Cells and Eradicate BRCA1-Deficient Mammary Tumors in Mice.
Clin Cancer Res
; 23(22): 7020-7033, 2017 Nov 15.
Artigo
Inglês
| MEDLINE | ID: mdl-28821557
8.
BRCA1185delAG tumors may acquire therapy resistance through expression of RING-less BRCA1.
J Clin Invest
; 126(8): 2903-18, 2016 08 01.
Artigo
Inglês
| MEDLINE | ID: mdl-27454287
9.
Each of the four intracellular cysteines of CD36 is essential for insulin- or AMP-activated protein kinase-induced CD36 translocation.
Arch Physiol Biochem
; 120(1): 40-9, 2014 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-24377880
10.
A high-throughput functional complementation assay for classification of BRCA1 missense variants.
Cancer Discov
; 3(10): 1142-55, 2013 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-23867111
11.
Loss of 53BP1 causes PARP inhibitor resistance in Brca1-mutated mouse mammary tumors.
Cancer Discov
; 3(1): 68-81, 2013 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-23103855
12.
BRCA1 RING function is essential for tumor suppression but dispensable for therapy resistance.
Cancer Cell
; 20(6): 797-809, 2011 Dec 13.
Artigo
Inglês
| MEDLINE | ID: mdl-22172724